ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Cigarette Smokers Are Dying Of Lung Cancer More Often Than Of Heart Disease, Study Finds

August 30, 1991

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

January 25, 2013

Cancer Groups Oppose Plan To Cut Drug Reimbursement.

July 28, 2000

AACR Presents Awards At Annual Meeting

April 23, 2010

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014